Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vanessa Bassan"'
Autor:
Nevin John, Jeremy Chataway, Jacqueline Palace, Gavin Giovannoni, David Paling, Frederik Barkhof, Floriana De Angelis, Lorraine Smith, Thomas Williams, Martin Duddy, James Overell, Basil Sharrack, Sebastien Ourselin, Allan Walker, Siddharthan Chandran, Richard Nicholas, Shuna Colville, Peter Connick, Carolyn Young, Jeremy Hobart, Anisha Doshi, Sharmilee Gnanapavan, Helen Ford, Baljean Dhillon, Thanh Phan, Arman Eshaghi, Julia Aram, Nigel Stallard, James Cameron, Brendan McLean, Matthew Craner, Domenico Plantone, Jonathan Stutters, Ferran Prados Carrasco, Marie Braisher, Moira Ross, Gina Cranswick, Sue H Pavitt, Clive Hawkins, Roger Bastow, Daisy Mollison, Waqar Rashid, Joe Guadagno, Nikolaos Evangelou, Seema Kalra, Alberto Calvi, Yingtong Li, Tiggy Beyene, Vanessa Bassan, Alvin Zapata, Dawn Lyle, Heinke Arndt
Publikováno v:
BMJ Neurology Open, Vol 6, Iss 2 (2024)
Background The brain reserve hypothesis posits that larger maximal lifetime brain growth (MLBG) may confer protection against physical disability in multiple sclerosis (MS). Larger MLBG as a proxy for brain reserve, has been associated with reduced p
Externí odkaz:
https://doaj.org/article/03779c5cc9264a67966bb74f4a5ef24d
Autor:
Jeremy Chataway, Floriana De Angelis, Peter Connick, Richard A Parker, Domenico Plantone, Anisha Doshi, Nevin John, Jonathan Stutters, David MacManus, Ferran Prados Carrasco, Frederik Barkhof, Sebastien Ourselin, Marie Braisher, Moira Ross, Gina Cranswick, Sue H Pavitt, Gavin Giovannoni, Claudia Angela Gandini Wheeler-Kingshott, Clive Hawkins, Basil Sharrack, Roger Bastow, Christopher J Weir, Nigel Stallard, Siddharthan Chandran, Claudia A.M. Gandini Wheeler-Kingshott, Thomas Williams, Tiggy Beyene, Vanessa Bassan, Alvin Zapata, Dawn Lyle, James Cameron, Daisy Mollison, Shuna Colville, Baljean Dhillon, Christopher J. Weir, Richard A. Parker, Sharmilee Gnanapavan, Richard Nicholas, Waqar Rashid, Julia Aram, Helen Ford, James Overell, Carolyn Young, Heinke Arndt, Martin Duddy, Joe Guadagno, Nikolaos Evangelou, Matthew Craner, Jacqueline Palace, Jeremy Hobart, David Paling, Seema Kalra, Brendan McLean
Publikováno v:
Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, Macmanus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J & Stallard, N & Chandran, S 2020, ' Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 3, pp. 214-225 . https://doi.org/10.1016/S1474-4422(19)30485-5
O2, repositorio institucional de la UOC
Universitat Oberta de Catalunya (UOC)
Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, MacManus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-Kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J, Stallard, N, Chandran, S & MS-SMART Investigators 2020, ' Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 3, pp. 214-225 . https://doi.org/10.1016/S1474-4422(19)30485-5
The Lancet Neurology, 19(3), 214-225. Lancet Publishing Group
O2, repositorio institucional de la UOC
Universitat Oberta de Catalunya (UOC)
Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, MacManus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-Kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J, Stallard, N, Chandran, S & MS-SMART Investigators 2020, ' Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 3, pp. 214-225 . https://doi.org/10.1016/S1474-4422(19)30485-5
The Lancet Neurology, 19(3), 214-225. Lancet Publishing Group
Background:\ud Neurodegeneration is the pathological substrate that causes major disability in secondary progressive multiple sclerosis. A synthesis of preclinical and clinical research identified three neuroprotective drugs acting on different axona
Autor:
Mario Teo, Mathew R. Guilfoyle, Carole Turner, Peter J. Kirkpatrick, Carole L. Turner, Gordon D. Murray, Peter J. Hutchinson, Graham Teasdale, A. David Mendelow, Keith Muir, Martin Smith, Peter McCabe, Jeremy Pearson, Gary Ford, Andrew Vail, Andrew King, Pippa Tyrrell, Hugh Richards, Simon Bond, Christopher Smith, Elizabeth Warburton, Ming Tseng, Diederik Bulters, Martina Brown, Giles Critchley, Gavin Spurling, Jane Gaylard, Mohsen Javadpour, Paul Eldridge, Lorna Murray, Richard Nelson, Ros Taylor, Sarah Hierons, Bianca Tobin, Kelley Storey, Daniel Walsh, Bejal Mistry, John Aeron-Thomas, Corina Puppo, Mario Papadopoulos, Laura Montague, Peter Gan, Graham Flint, Jennie Hurley, Elizabeth Ronne, Inger Stjernling, Ernest Wang, Ei Leen Cheng, Jing Li Lai, Stuart Ross, Ruth Bellfield, Linetty Mandizvidza, Peter Whitfield, Nicola Persad, Nigel Suttner, Kate McGuigan, Linda Cloughley, Hiren Patel, Andrea Ingham, Kellymarie Shaw, Raghu Vindlacheruvu, Julian Millo, Orlando Warner, Rachel Teal, Francis Bernard, Carol Sirois, Shaban Joshi, Sheila Nyabadza, Joan Grieve, Neil Kitchen, Vanessa Bassan, Philip Rayson, Alexander Zeitlin, Max Findlay, Leeca Sonnema, Brenda Poworoznik, Juan Quintero, Sam Eljamel, Frank Rasulo, Ivan Ng, Bruce Mathew, Jill Grieg, Ricardo Hanel, Alexa Richie, Ian Fleetwood, Elizabeth Reardon-White, Ginger Hampton, Stephen Lewis, Lynn Miralia, Howard Brydon, Holly Maguire, Umang Patel, Helen Sanderson, Kathryn Birchall, Pauline Bayliss, Kevin O'Neill, Tina Sachs, Rupert Kett-White, Leanne Quinn
Background The management of aneurysmal subarachnoid hemorrhage (aSAH) has changed dramatically in the last few decades with the publication of a few major studies, including ISAT (International Subarachnoid Aneurysm Trial, the International Cooperat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::880d7d35873554bd6cb87b4d3585a885
http://hdl.handle.net/11379/499563
http://hdl.handle.net/11379/499563